Drug Type Monoclonal antibody |
Synonyms AZD2743, AZD6067, AZD6213 + [2] |
Mechanism C5AR1 antagonists(C5a anaphylatoxin chemotactic receptor antagonists), G-CSF antagonists(Granulocyte colony-stimulating factor antagonists), MMP12 inhibitors(Matrix metalloproteinase 12 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Disease, Chronic Obstructive | Preclinical | US | - | |
Pulmonary Disease, Chronic Obstructive | Preclinical | EU | - |